A team of investigators conducted a large retrospective, cohort study to assess whether a longitudinal link exists between H pylori infection and the risk of developing dyslipidemia.
Lipoprotein apheresis was associated with reduced concentrations of LDL-C and Lp(a) in patients with hyperlipoproteinemia (a) and FH on a maximally tolerated lipid-lowering regimen.
The objective was to study the incidence of acute pancreatitis, ischemic cardiovascular disease, and diabetes in hyperchylomicronemic patients with FCS and MCS compared with the general population.
In this phase 2 trial, patients with hypercholesterolemia and clinical atherosclerotic cardiovascular disease were recruited from 85 sites across 20 countries.
Elevated LDL-C polygenic scores associated with higher LDL-C levels and increased risk for ASCVD in patients with monogenic familial hypercholesterolemia.
Elevated LDL-C levels in people ages 70 to 100 years were found to be associated with a higher absolute risk for myocardial infarction and atherosclerotic cardiovascular disease.
